Greenwich Lifesciences, Inc. · NASDAQ:GLSI
Patel Snehal bought 2,200 Greenwich Lifesciences, Inc. shares (Form 4)
Traded Jul 28 to Jul 29, 2026 · Filed Jul 30, 2026
From Jul 28 to Jul 29, 2026, Patel Snehal (Director, CEO and CFO, 10% owner) bought 2,200 Greenwich Lifesciences, Inc. shares at an average US$13.43 for US$29,555, leaving 5,611,402 shares. Filed Jul 30, 2026 (Form 4).
- Bought
- 2,200 shares
- Price
- US$13.43 average (US$13.10 to US$13.59)
- Value
- US$29,555
- Holding after
- 5,611,402 shares
- Trading plan
- No
- Role
- Director, CEO and CFO, 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 28, 2026 | Common Stock | Buy | 1,500 | US$13.59 | 5,610,702 | Direct |
| Jul 29, 2026 | Common Stock | Buy | 700 | US$13.10 | 5,611,402 | Direct |